Biblio

Export 3285 results:
Author Title Type [ Year(Asc)]
Filters: Filter is   [Clear All Filters]
2017
S. A. Chau, Herrmann, N., Sherman, C., Chung, J., Eizenman, M., Kiss, A., and Lanctôt, K. L., “Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1339-1349, 2017.
R. Valenti, Charidimou, A., Xiong, L., Boulouis, G., Fotiadis, P., Ayres, A., Riley, G., Kuijf, H. J., Reijmer, Y. D., Pantoni, L., M Gurol, E., Davidsdottir, S., Greenberg, S. M., and Viswanathan, A., “Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1223-1227, 2017.
S. Licher, de Bruijn, R. F. A. G., Wolters, F. J., M Zillikens, C., M Ikram, A., and M Ikram, K., “Vitamin D and the Risk of Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 989-997, 2017.
G. A. Laughlin, Kritz-Silverstein, D., Bergstrom, J., Reas, E. T., Jassal, S. K., Barrett-Connor, E., and McEvoy, L. K., “Vitamin D Insufficiency and Cognitive Function Trajectories in Older Adults: The Rancho Bernardo Study.”, J Alzheimers Dis, vol. 58, no. 3, pp. 871-883, 2017.
L. Tremolizzo, Bianchi, E., Susani, E., Pupillo, E., Messina, P., Aliprandi, A., Salmaggi, A., Cosseddu, M., Pilotto, A., Borroni, B., Padovani, A., Bonomini, C., Zanetti, O., Appollonio, I., Beghi, E., and Ferrarese, C., “Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study.”, J Alzheimers Dis, vol. 60, no. 2, pp. 335-340, 2017.
Y. Yang, Halliday, G. M., Hodges, J. R., and Tan, R. H., “von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion.”, J Alzheimers Dis, vol. 58, no. 3, pp. 701-709, 2017.
R. Mc Ardle, Morris, R., Wilson, J., Galna, B., Thomas, A. J., and Rochester, L., “What Can Quantitative Gait Analysis Tell Us about Dementia and Its Subtypes? A Structured Review.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1295-1312, 2017.
C. Reed, Happich, M., Argimon, J. Maria, Haro, J. Maria, Wimo, A., Bruno, G., Dodel, R., Jones, R. W., Vellas, B., and Belger, M., “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
J. A. Yates, Clare, L., and Woods, R. T., “What is the Relationship between Health, Mood, and Mild Cognitive Impairment?”, J Alzheimers Dis, vol. 55, no. 3, pp. 1183-1193, 2017.
M. F. Mendez, “What is the Relationship of Traumatic Brain Injury to Dementia?”, J Alzheimers Dis, vol. 57, no. 3, pp. 667-681, 2017.
J. M. Robillard and Feng, T. L., “When Patient Engagement and Research Ethics Collide: Lessons from a Dementia Forum.”, J Alzheimers Dis, vol. 59, no. 1, pp. 1-10, 2017.
A. Gerstenecker, Hoagey, D. A., Marson, D. C., and Kennedy, K. M., “White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 537-547, 2017.
W. M. Freeze, Jacobs, H. I. L., Gronenschild, E. H., Jansen, J. F. A., Burgmans, S., Aalten, P., Clerx, L., Vos, S. J., van Buchem, M. A., Barkhof, F., van der Flier, W. M., Verbeek, M. M., Rikkert, M. Olde, Backes, W. H., and Verhey, F. R., “White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.”, J Alzheimers Dis, vol. 55, no. 1, pp. 333-342, 2017.
H. Borghys, Van Broeck, B., Dhuyvetter, D., Jacobs, T., de Waepenaert, K., Erkens, T., Brooks, M., Thevarkunnel, S., and Araujo, J. A., “Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.”, J Alzheimers Dis, vol. 56, no. 2, pp. 763-774, 2017.
2016
H. - L. Gao, Li, C., Nabeka, H., Shimokawa, T., Wang, Z. - Y., Cao, Y. - M., and Matsuda, S., “An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1173-92, 2016.
A. Boehm-Cagan, Bar, R., Liraz, O., Bielicki, J. K., Johansson, J. O., and Michaelson, D. M., “ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1219-1233, 2016.
Q. - F. Zhao, Wan, Y., Wang, H. - F., Sun, F. - R., Hao, X. - K., Tan, M. - S., Tan, C. - C., Zhang, D. - Q., Tan, L., and Yu, J. - T., “ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.”, J Alzheimers Dis, vol. 52, no. 2, pp. 693-703, 2016.
Y. H. Fu, Hsiao, J. - H. T., Paxinos, G., Halliday, G. M., and Kim, W. Scott, “ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain.”, J Alzheimers Dis, vol. 54, no. 2, pp. 569-84, 2016.
L. Ni, Liu, R., Yin, Z., Zhao, H., Nedelska, Z., Hort, J., Zhou, F., Wu, W., Zhang, X., Li, M., Yu, H., Zhu, B., Xu, Y., and Zhang, B., “Aberrant Spontaneous Brain Activity in Patients with Mild Cognitive Impairment and concomitant Lacunar Infarction: A Resting-State Functional MRI Study.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1243-54, 2016.
J. Dukart, Sambataro, F., and Bertolino, A., “Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1143-59, 2016.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
T. C. Durazzo, Korecka, M., Trojanowski, J. Q., Weiner, M. W., Hara, R. O. ', Ashford, J. W., and Shaw, L. M., “Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.”, J Alzheimers Dis, vol. 54, no. 1, pp. 99-107, 2016.
E. Stogmann, Moser, D., Klug, S., Gleiss, A., Auff, E., Dal-Bianco, P., Pusswald, G., and Lehrner, J., “Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1043-50, 2016.
R. L. H. Handels, Joore, M. A., Vos, S. J. B., Aalten, P., Ramakers, I. H. G. B., Rikkert, M. Olde, Scheltens, P., Jansen, W. J., Visser, P. - J., van Berckel, B. M. N., van Domburg, P., Smid, M., Hoff, E., Hoogmoed, J., Bouwman, F., Claassen, J., Leentjens, A. F. G., Wolfs, C. A. G., Severens, J. L., and Verhey, F. R. J., “Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort.”, J Alzheimers Dis, vol. 52, no. 3, pp. 875-85, 2016.
B. Arosio, Casati, M., Gussago, C., Ferri, E., Abbate, C., Scortichini, V., Colombo, E., Rossi, P. Dionigi, and Mari, D., “Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target.”, J Alzheimers Dis, vol. 54, no. 2, pp. 417-25, 2016.

Pages